X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2317) 2317
Publication (223) 223
Newsletter (57) 57
Newspaper Article (42) 42
Book Review (11) 11
Book Chapter (9) 9
Magazine Article (3) 3
Book / eBook (2) 2
Conference Proceeding (2) 2
Data Set (1) 1
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1284) 1284
animals (1012) 1012
male (908) 908
index medicus (794) 794
cyclohexane (695) 695
female (683) 683
cyclohexanes - pharmacology (534) 534
rats (424) 424
mice (420) 420
cyclohexanes (419) 419
cyclohexanes - therapeutic use (394) 394
adult (372) 372
middle aged (357) 357
pharmacology & pharmacy (343) 343
phenylalanine - analogs & derivatives (277) 277
analysis (275) 275
cyclohexanes - administration & dosage (244) 244
nateglinide (199) 199
aged (197) 197
sesquiterpenes - pharmacology (190) 190
time factors (188) 188
oncology (167) 167
hiv infections - drug therapy (166) 166
cyclohexanes - pharmacokinetics (155) 155
hypoglycemic agents - therapeutic use (154) 154
dose-response relationship, drug (148) 148
maraviroc (144) 144
cancer (139) 139
biochemistry & molecular biology (137) 137
cyclohexanes - adverse effects (136) 136
diabetes mellitus, type 2 - drug therapy (136) 136
angiogenesis (135) 135
phenylalanine - therapeutic use (135) 135
research (135) 135
endocrinology & metabolism (133) 133
sesquiterpenes - therapeutic use (130) 130
blood pressure - drug effects (126) 126
triazoles - therapeutic use (125) 125
article (123) 123
cyclohexanes - blood (122) 122
hiv (120) 120
toxicology (117) 117
immunology (116) 116
infectious diseases (116) 116
tnp-470 (115) 115
expression (114) 114
treatment outcome (114) 114
chlorhexidine (113) 113
cyclohexanes - chemistry (111) 111
angiogenesis inhibitors - pharmacology (109) 109
cyclohexanes - metabolism (109) 109
in-vitro (109) 109
fumagillin (107) 107
triazoles - pharmacology (106) 106
health aspects (103) 103
hypoglycemic agents - pharmacology (103) 103
tumor-growth (101) 101
drug therapy, combination (100) 100
blood glucose - metabolism (99) 99
adolescent (98) 98
phenylalanine - pharmacology (98) 98
o-fumagillol (96) 96
agm-1470 (94) 94
neovascularization, pathologic - drug therapy (94) 94
rats, sprague-dawley (92) 92
disease models, animal (91) 91
carbocyclic compounds (90) 90
dentistry (90) 90
microbiology (89) 89
hiv-1 - drug effects (88) 88
therapy (88) 88
ccr5 receptor antagonists (87) 87
cyclohexanes - toxicity (87) 87
hiv infections - virology (86) 86
hypoglycemic agents - administration & dosage (85) 85
administration, oral (84) 84
double-blind method (84) 84
apoptosis (80) 80
mice, inbred c57bl (80) 80
cells (79) 79
chemistry, medicinal (79) 79
glucose (78) 78
rabbits (78) 78
rats, wistar (78) 78
antiviral agents (77) 77
metastasis (77) 77
insulin - blood (76) 76
insulin secretion (76) 76
ketamine (76) 76
pharmacokinetics (76) 76
cells, cultured (75) 75
insulin - metabolism (74) 74
growth (73) 73
virology (73) 73
dogs (70) 70
drug therapy (70) 70
neovascularization, pathologic - prevention & control (70) 70
phenylalanine - administration & dosage (70) 70
in vitro techniques (69) 69
care and treatment (68) 68
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2264) 2264
German (63) 63
Japanese (55) 55
French (11) 11
Italian (11) 11
Chinese (10) 10
Russian (8) 8
Danish (4) 4
Spanish (2) 2
Hungarian (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Orthopaedics and Related Research, ISSN 0009-921X, 10/2011, Volume 469, Issue 10, pp. 2874 - 2880
Journal Article
Obesity, ISSN 1930-7381, 09/2013, Volume 21, Issue 9, pp. 1782 - 1788
Objective: Evaluate the safety and tolerability of beloranib, a fumagillin‐class methionine aminopetidase‐2 (MetAP2) inhibitor, in obese women over 4 weeks.... 
AGENT | NUTRITION & DIETETICS | RISK-FACTORS | TNP-470 | ANALOG | CKD-732 | GROWTH | MASS | ENDOCRINOLOGY & METABOLISM | ADULTS | RANDOMIZED CONTROLLED-TRIAL | INHIBITOR | Blood Pressure | Obesity - drug therapy | Cyclohexanes - pharmacology | Humans | Middle Aged | Aspergillus - chemistry | Anti-Obesity Agents - adverse effects | Fatty Acids, Unsaturated - therapeutic use | Biological Products - pharmacology | Weight Loss - drug effects | Obesity - blood | Anti-Obesity Agents - therapeutic use | Sesquiterpenes - adverse effects | Sesquiterpenes - therapeutic use | Cyclohexanes - therapeutic use | Hunger - drug effects | C-Reactive Protein - metabolism | Leptin - blood | Lipids - blood | Biological Products - adverse effects | Cholesterol, LDL - blood | Female | Cyclohexanes - adverse effects | Biological Products - therapeutic use | Double-Blind Method | 3-Hydroxybutyric Acid - blood | Glycoproteins - antagonists & inhibitors | Fatty Acids, Unsaturated - pharmacology | Aminopeptidases - antagonists & inhibitors | Adiponectin - blood | Fibroblast Growth Factors - blood | Fatty Acids, Unsaturated - adverse effects | Triglycerides - blood | Infusions, Intravenous | Sesquiterpenes - pharmacology | Blood Glucose - metabolism | Anti-Obesity Agents - pharmacology | Studies | Obesity | Angiogenesis | Weight control | Womens health | Laboratories | Clinical trials | Lipids | Drug dosages | Risk factors | Methods | Molecular weight
Journal Article
Journal of Biomedical Materials Research - Part B Applied Biomaterials, ISSN 1552-4973, 04/2018, Volume 106, Issue 3, pp. 1052 - 1063
Journal Article
Journal Article
AIDS, ISSN 0269-9370, 07/2017, Volume 31, Issue 11, pp. 1529 - 1534
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 16, pp. 1477 - 1490
In this large clinical trial, the angiotensin-receptor blocker valsartan reduced the risk of diabetes in patients with impaired glucose tolerance. However, the... 
FASTING GLUCOSE | TRIAL | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | LIFE-STYLE INTERVENTIONS | DISEASE | PREVENTION | COMPONENTS | IMPAIRED GLUCOSE-TOLERANCE | MELLITUS | CONVERTING-ENZYME-INHIBITORS | Angiotensin II Type 1 Receptor Blockers - adverse effects | Follow-Up Studies | Phenylalanine - analogs & derivatives | Valsartan | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Body Weight - drug effects | Male | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Cyclohexanes - therapeutic use | Glucose Intolerance - drug therapy | Exercise | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Phenylalanine - therapeutic use | Drug Therapy, Combination | Hypoglycemic Agents - therapeutic use | Blood Glucose - analysis | Double-Blind Method | Risk Factors | Valine - analogs & derivatives | Diabetes Mellitus, Type 2 - prevention & control | Proportional Hazards Models | Blood Glucose - drug effects | Glucose Intolerance - diet therapy | Tetrazoles - therapeutic use | Valine - therapeutic use | Tetrazoles - adverse effects | Valine - adverse effects | Glucose Intolerance - therapy | Evaluation | Care and treatment | Glucose intolerance | Diabetes | Cardiovascular diseases | Drug therapy | Cardiovascular disease | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 4/2013, Volume 207, Issue 8, pp. 1226 - 1234
Background. Effective antiretroviral therapy (ART) dramatically reduces human immunodeficiency virus (HIV) transmission. However, isolated shedding of HIV type... 
HIV/AIDS | Antiretrovirals | HIV | RNA | Semen | Men | Viruses | Viral load | Blood | HIV 1 | Blood plasma | semen | transmission | viral load | antiretroviral therapy | INFECTIOUS DISEASES | RALTEGRAVIR | BLOOD-PLASMA | MICROBIOLOGY | TREATED PATIENTS | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | SEMINAL PLASMA SAMPLES | PROTEASE INHIBITORS | MALE GENITAL-TRACT | HIV-1-INFECTED MEN | INFECTED PATIENTS | HIV-1 - pathogenicity | Prospective Studies | Triazoles - blood | Cyclohexanes - pharmacology | Humans | Molecular Sequence Data | Male | RNA, Viral - blood | Virus Shedding | Case-Control Studies | Viral Load | Incidence | Cyclohexanes - therapeutic use | RNA, Viral - genetics | Time Factors | Base Sequence | Pyrrolidinones - pharmacology | HIV Infections - transmission | Anti-Retroviral Agents - blood | Semen - virology | Raltegravir Potassium | Triazoles - therapeutic use | Amino Acid Sequence | Anti-Retroviral Agents - therapeutic use | Sexual Behavior | HIV Infections - virology | Anti-Retroviral Agents - pharmacology | Pyrrolidinones - therapeutic use | Pyrrolidinones - blood | Treatment Outcome | HIV-1 - genetics | Cyclohexanes - blood | Triazoles - pharmacology | Sequence Analysis, RNA | Viremia - virology | HIV Infections - drug therapy | Antiviral agents | Development and progression | Genetic aspects | Dosage and administration | Research | HIV infection
Journal Article